Follow
Tracy R Melzer
Tracy R Melzer
University of Otago, New Zealand Brain Research Institute
Verified email at nzbri.org - Homepage
Title
Cited by
Cited by
Year
The MoCA: well-suited screen for cognitive impairment in Parkinson disease
JC Dalrymple-Alford, MR MacAskill, CT Nakas, L Livingston, C Graham, ...
Neurology 75 (19), 1717-1725, 2010
10012010
The genetic architecture of the human cerebral cortex
KL Grasby, N Jahanshad, JN Painter, L Colodro-Conde, J Bralten, ...
Science 367 (6484), eaay6690, 2020
6602020
Grey matter atrophy in cognitively impaired Parkinson's disease
TR Melzer, R Watts, MR MacAskill, TL Pitcher, L Livingston, RJ Keenan, ...
Journal of Neurology, Neurosurgery & Psychiatry 83 (2), 188-194, 2012
3252012
General functional connectivity: Shared features of resting-state and task fMRI drive reliable and heritable individual differences in functional brain networks
ML Elliott, AR Knodt, M Cooke, MJ Kim, TR Melzer, R Keenan, D Ireland, ...
NeuroImage 189, 516-532, 2019
2792019
Brain-age in midlife is associated with accelerated biological aging and cognitive decline in a longitudinal birth cohort
ML Elliott, DW Belsky, AR Knodt, D Ireland, TR Melzer, R Poulton, ...
Molecular psychiatry 26 (8), 3829-3838, 2021
2192021
Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson’s disease
TR Melzer, R Watts, MR MacAskill, JF Pearson, S Rüeger, TL Pitcher, ...
Brain 134 (3), 845-855, 2011
2092011
Characterizing mild cognitive impairment in Parkinson's disease
JC Dalrymple‐Alford, L Livingston, MR MacAskill, C Graham, TR Melzer, ...
Movement Disorders 26 (4), 629-636, 2011
1932011
Disparities in the pace of biological aging among midlife adults of the same chronological age have implications for future frailty risk and policy
ML Elliott, A Caspi, RM Houts, A Ambler, JM Broadbent, RJ Hancox, ...
Nature aging 1 (3), 295-308, 2021
1852021
White matter microstructure deteriorates across cognitive stages in Parkinson disease
TR Melzer, R Watts, MR MacAskill, TL Pitcher, L Livingston, RJ Keenan, ...
Neurology 80 (20), 1841-1849, 2013
1812013
Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis
L Debernard, TR Melzer, S Van Stockum, C Graham, ...
Journal of Neurology, Neurosurgery & Psychiatry 85 (5), 544-551, 2014
1142014
Bio-medical X-ray imaging with spectroscopic pixel detectors
APH Butler, NG Anderson, R Tipples, N Cook, R Watts, J Meyer, AJ Bell, ...
Nuclear Instruments and Methods in Physics Research Section A: Accelerators …, 2008
1102008
Comparing cerebral perfusion in Alzheimer's disease and Parkinson's disease dementia: an ASL-MRI study
CJL Heron, SL Wright, TR Melzer, DJ Myall, MR MacAskill, L Livingston, ...
Journal of Cerebral Blood Flow & Metabolism 34 (6), 964-970, 2014
892014
Pervasively thinner neocortex as a transdiagnostic feature of general psychopathology
AL Romer, ML Elliott, AR Knodt, ML Sison, D Ireland, R Houts, ...
American Journal of Psychiatry 178 (2), 174-182, 2021
832021
Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study
KL Wood, DJ Myall, L Livingston, TR Melzer, TL Pitcher, MR MacAskill, ...
npj Parkinson's Disease 2 (1), 1-8, 2016
832016
Associations between life-course-persistent antisocial behaviour and brain structure in a population-representative longitudinal birth cohort
CO Carlisi, TE Moffitt, AR Knodt, H Harrington, D Ireland, TR Melzer, ...
The Lancet Psychiatry 7 (3), 245-253, 2020
822020
Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis
L Debernard, TR Melzer, S Alla, J Eagle, S Van Stockum, C Graham, ...
Psychiatry Research: Neuroimaging 234 (3), 352-361, 2015
772015
International multicenter analysis of brain structure across clinical stages of Parkinson's disease
MA Laansma, JK Bright, S Al‐Bachari, TJ Anderson, T Ard, F Assogna, ...
Movement disorders 36 (11), 2583-2594, 2021
762021
Longitudinal in vivo monitoring of the CNS demonstrates the efficacy of gene therapy in a sheep model of CLN5 Batten disease
NL Mitchell, KN Russell, MP Wellby, HE Wicky, L Schoderboeck, ...
Molecular Therapy 26 (10), 2366-2378, 2018
752018
Beta amyloid deposition is not associated with cognitive impairment in Parkinson's disease
TR Melzer, MR Stark, RJ Keenan, DJ Myall, MR MacAskill, TL Pitcher, ...
Frontiers in neurology 10, 391, 2019
712019
White matter hyperintensities are common in midlife and already associated with cognitive decline
T d’Arbeloff, ML Elliott, AR Knodt, TR Melzer, R Keenan, D Ireland, ...
Brain Communications 1 (1), fcz041, 2019
702019
The system can't perform the operation now. Try again later.
Articles 1–20